Incidence and Outcomes of Cytomegalovirus Reactivation after Chimeric Antigen Receptor T Cell Therapy.
Lin RY, Anderson AD, Natori Y, Raja M, Morris MI, Jimenez Jimenez AM, Beitinjaneh A, Wang T, Goodman M, Lekakis LJ, Spiegel JY, Holtzman NG, Pereira DL, Benjamin CL, Natori A, Komanduri KV, Camargo JF.
Lin RY, et al. Among authors: anderson ad.
Blood Adv. 2024 Jun 5:bloodadvances.2024012922. doi: 10.1182/bloodadvances.2024012922. Online ahead of print.
Blood Adv. 2024.
PMID: 38838226